This bill expands paid family and medical leave for federal employees by increasing total entitlement from 12 to 26 weeks annually. It modifies existing laws to cover all federal workers (including those at the GAO, USPS, Library of Congress, and congressional staff), replacing "parental leave" with broader "family and medical leave" and adding 14 additional weeks for qualifying events like childbirth, adoption, or serious health conditions. Employees who already used paid leave under other programs will have their new entitlement reduced by the days already taken. The changes apply immediately to most federal employees, with specific timelines for agencies like the Veterans Affairs Department and District of Columbia courts.
This is a commemorative resolution (HRES 55), not a policy bill. It formally recognizes Certified Registered Nurse Anesthetists (CRNAs) for their 150+ year service in providing anesthesia care across the U.S., including in rural areas, military facilities, and during public health emergencies like the pandemic. The resolution thanks CRNAs for their "incredible, selfless, and dedicated service" and encourages the public and healthcare stakeholders to acknowledge their work during National CRNA Week (January 23-28, 2023). It has no legal effect or policy changes - it is purely symbolic recognition.
The Better Care Better Jobs Act (HR 547) aims to improve access to home and community-based services (HCBS) for Medicaid beneficiaries by providing states with planning grants and enhanced federal funding. States that develop approved HCBS infrastructure improvement plans will receive a 10 percentage point increase in federal Medicaid funding for HCBS services, with additional incentives for self-directed care programs. The bill requires states to address barriers to access, expand workforce development, improve payment rates for direct care workers, and track demographic data on service utilization. It also establishes quality measurement requirements and mandates regular reporting on progress toward improving HCBS access and quality.
HRES 94 is a symbolic House resolution (introduced February 2023) that formally honors the Harlem Renaissance - a cultural movement spanning the 1910s to 1930s. It recognizes the movement’s role in redefining Black identity through literature, music, art, and political thought, highlighting figures like Langston Hughes, Duke Ellington, and organizations such as the NAACP. The resolution does not create new laws or policies; it solely commemorates the movement’s historical significance, its influence on civil rights, and its lasting impact on American culture, while affirming support for preserving Harlem’s cultural legacy.
This resolution states that the House of Representatives (1) rejects hate, discrimination, and antisemitism; (2) stands united with the Jewish people against rising antisemitism; and (3) condemns antisemitic tropes such as claims of dual loyalty.
This bill creates a federal grant program to help states and tribes implement Extreme Risk Protection Orders (ERPOs), which allow courts to temporarily remove firearms from individuals who may pose a danger to themselves or others. To qualify for funding, states must have laws including due process protections like hearings before orders are issued. The bill also amends federal law to include ERPOs in background checks and requires states to notify federal databases about these orders. It ensures ERPOs issued in one state will be recognized by courts in other states. This would directly affect individuals subject to ERPOs, law enforcement officers, and courts that implement these orders.
The Stop Spying Bosses Act requires employers to disclose workplace surveillance practices to employees and job applicants, including what data is collected, how it's collected, where it's stored, and how it affects employment decisions. It prohibits employers from using surveillance to monitor labor organizing activities, off-duty behavior, political views, religious activities, or health information unrelated to job duties, and bans selling employee data. The bill establishes a new Privacy and Technology Division within the Department of Labor to oversee implementation and enforcement. It also provides employees with the right to review and correct their data and includes whistleblower protections for those reporting violations.
The Protecting America's Meatpacking Workers Act of 2023 aims to improve safety and working conditions for meat and poultry processing workers, who face high injury rates, including double the amputation rate of other workers and widespread musculoskeletal disorders. The bill prohibits "no fault attendance policies" that penalize workers for taking legally protected leave, requires employers to provide adequate toilet facilities without punishment, and establishes new OSHA standards for ergonomic programs and protection from airborne illnesses like COVID-19. It also increases OSHA inspector funding by $60 million annually, expands workplace inspections focusing on line speeds and safety hazards, and strengthens protections for workers who report safety concerns without fear of retaliation. The bill directly affects meatpacking facilities and their workers nationwide, particularly those who experienced heightened risks during the pandemic.
This bill requires the Federal Trade Commission to create rules within one year banning gun manufacturers, dealers, and importers from marketing firearms or related products (including accessories and ammunition) to people under 18. It specifically prohibits tactics like using cartoon characters, kids' merchandise (e.g., hats or toys), or small-sized guns designed to appeal to minors. Enforcement would be led by the FTC, with states and individuals also able to pursue legal action for violations. The law defines "minor" as under 18 and applies to all firearm-related marketing, not just the products themselves.
This bill would significantly strengthen pesticide regulations by requiring the EPA to immediately suspend registration of pesticides that may cause cancer, neurological harm, or other serious risks if they aren't reviewed within specified timeframes. It would ban the use of organophosphate pesticides, neonicotinoids, and paraquat, which have been linked to health problems in children and environmental harm to pollinators. The bill also mandates full disclosure of all ingredients on pesticide labels, including inert chemicals that can be toxic, and creates a mandatory reporting system for farmworker pesticide exposure incidents with penalties for non-compliance. These changes would directly affect pesticide manufacturers, farmers, and farmworkers, while aiming to protect children, communities, and the environment from harmful pesticide exposure.
The Industrial Agriculture Accountability Act of 2023 establishes new requirements for large industrial agricultural operations that house significant numbers of livestock or poultry (defined as "covered industrial operators"). It mandates registration with a new Office of High-Risk AFO Disaster Mitigation and Enforcement, requiring detailed disaster mitigation plans and annual fees of at least $1 per animal unit. The bill restricts inhumane depopulation methods like ventilation shutdown and sodium nitrite poisoning, while creating labor protections including health insurance coverage and severance pay for workers during disaster events. Additionally, the legislation includes provisions for humane handling of livestock during transport and slaughter, ending certain dangerous slaughter speed systems, and authorizes funding for additional inspectors to enforce these standards.
S 237, the Protecting Access to Medication Abortion Act of 2023, modifies federal safety requirements for mifepristone (used in medication abortions) to expand access. The bill requires the FDA to remove in-person dispensing rules, allow telehealth prescriptions, and permit certified pharmacies to mail the drug directly to patients. It directly affects patients seeking medication abortion and healthcare providers/pharmacies dispensing mifepristone. The law mandates these changes for mifepristone’s risk evaluation and mitigation strategy (REMS), while preserving FDA authority to adjust safety measures based on scientific evidence.
